Physician profile
Ryan Akin
NPI 1437738861
$2,857.75
in general payments reported to CMS, 2019-2025
12 companies · $763 in 2025
The $763 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.59 · 2022: $89.11 · 2023: $305 · 2024: $1,618 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572 · Travel and Lodging: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,572.08 |
| Travel and Lodging | $1,112.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,903.13 | 2021-2025 | Na, Smartlock, Scopis Ent |
| Astrazeneca Pharmaceuticals Lp | $250.40 | 2025 | Tezspire, Fasenra |
| Phathom Pharmaceuticals, INC. | $126.52 | 2024 | Voquezna |
| Glaxosmithkline, LLC. | $115.44 | 2023 | Nucala |
| Coopersurgical, INC. | $107.98 | 2025 | Cook |
| Integra Lifesciences Corporation | $100.84 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Inspire Medical Systems, INC. | $100.59 | 2025 | Inspire |
| Ambu INC. | $47.96 | 2022 | |
| Pharming Healthcare, INC. | $34.57 | 2023 | Ruconest |
| Baxter Healthcare | $30.66 | 2021 | |
| Biocryst US Sales Co., LLC | $23.39 | 2023 | Orladeyo |
| Novo Nordisk INC | $16.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Akin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.